Fielmann Aktiengesellschaft (FLMNF)
USD 46.75
(0.0%)
USD 46.75
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.98 Billion EUR | -2.67% |
| 2022 | 2.04 Billion USD | -3.93% |
| 2021 | 2.12 Billion USD | -3.15% |
| 2020 | 2.19 Billion USD | 32.27% |
| 2019 | 1.65 Billion USD | 75.54% |
| 2018 | 944.79 Million EUR | 2.06% |
| 2017 | 925.68 Million EUR | 1.33% |
| 2016 | 913.53 Million EUR | 2.52% |
| 2015 | 891.1 Million EUR | 6.42% |
| 2014 | 837.31 Million EUR | 4.74% |
| 2013 | 799.43 Million EUR | 6.13% |
| 2012 | 753.22 Million EUR | 3.53% |
| 2011 | 727.57 Million EUR | 5.43% |
| 2010 | 690.1 Million EUR | 7.53% |
| 2009 | 641.79 Million EUR | -1.98% |
| 2008 | 654.72 Million EUR | 12.58% |
| 2007 | 581.58 Million EUR | 9.06% |
| 2006 | 533.28 Million EUR | 6.33% |
| 2005 | 501.53 Million EUR | 12.29% |
| 2004 | 446.66 Million EUR | -16.89% |
| 2003 | 537.41 Million EUR | 41.54% |
| 2002 | 379.69 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q2 | 2.23 Billion EUR | 0.0% |
| 2023 Q4 | 1.98 Billion EUR | 0.0% |
| 2023 FY | 1.98 Billion EUR | -2.67% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q1 | 1.97 Billion USD | -3.04% |
| 2023 Q2 | 1.99 Billion USD | 0.75% |
| 2022 Q3 | 1.67 Billion USD | -6.11% |
| 2022 Q1 | 1.78 Billion EUR | 2.82% |
| 2022 Q2 | 1.78 Billion EUR | 0.11% |
| 2022 Q4 | 2.04 Billion USD | 21.67% |
| 2022 FY | 2.04 Billion USD | -3.93% |
| 2021 Q1 | 1.69 Billion EUR | 1.5% |
| 2021 FY | 2.12 Billion USD | -3.15% |
| 2021 Q4 | 1.73 Billion EUR | 1.22% |
| 2021 Q2 | 1.71 Billion EUR | 0.95% |
| 2021 Q3 | 1.71 Billion EUR | 0.27% |
| 2020 Q1 | 1.39 Billion EUR | 2.36% |
| 2020 Q2 | 1.37 Billion EUR | -1.96% |
| 2020 Q3 | 1.43 Billion EUR | 4.77% |
| 2020 Q4 | 1.66 Billion EUR | 16.18% |
| 2020 FY | 2.19 Billion USD | 32.27% |
| 2019 FY | 1.65 Billion USD | 75.54% |
| 2019 Q2 | 1.43 Billion EUR | 2.4% |
| 2019 Q3 | 1.35 Billion EUR | -5.48% |
| 2019 Q1 | 1.4 Billion EUR | 48.32% |
| 2019 Q4 | 1.36 Billion EUR | 0.76% |
| 2018 Q3 | 935.68 Million EUR | -6.79% |
| 2018 Q4 | 944.79 Million EUR | 0.97% |
| 2018 FY | 944.79 Million EUR | 2.06% |
| 2018 Q1 | 982.46 Million EUR | 6.13% |
| 2018 Q2 | 1 Billion EUR | 2.17% |
| 2017 Q1 | 1.03 Billion EUR | 13.46% |
| 2017 Q4 | 925.68 Million EUR | 2.41% |
| 2017 Q3 | 903.87 Million EUR | 6.26% |
| 2017 FY | 925.68 Million EUR | 1.33% |
| 2017 Q2 | 850.63 Million EUR | -17.93% |
| 2016 Q2 | 977.45 Million EUR | 4.72% |
| 2016 FY | 913.53 Million EUR | 2.52% |
| 2016 Q3 | 882.98 Million EUR | -9.66% |
| 2016 Q4 | 913.53 Million EUR | 3.46% |
| 2016 Q1 | 933.36 Million EUR | 4.74% |
| 2015 FY | 891.1 Million EUR | 6.42% |
| 2015 Q2 | 939.84 Million EUR | 2.57% |
| 2015 Q3 | 865.58 Million EUR | -7.9% |
| 2015 Q4 | 891.1 Million EUR | 2.95% |
| 2015 Q1 | 916.31 Million EUR | 9.43% |
| 2014 Q1 | 875.52 Million EUR | 9.52% |
| 2014 FY | 837.31 Million EUR | 4.74% |
| 2014 Q3 | 827.19 Million EUR | -7.35% |
| 2014 Q2 | 892.85 Million EUR | 1.98% |
| 2014 Q4 | 837.31 Million EUR | 1.22% |
| 2013 Q1 | 806.74 Million EUR | 7.1% |
| 2013 FY | 799.43 Million EUR | 6.13% |
| 2013 Q3 | 773.03 Million EUR | -7.18% |
| 2013 Q2 | 832.82 Million EUR | 3.23% |
| 2013 Q4 | 799.43 Million EUR | 3.41% |
| 2012 FY | 753.22 Million EUR | 3.53% |
| 2012 Q3 | 736.83 Million EUR | -8.74% |
| 2012 Q4 | 753.22 Million EUR | 2.23% |
| 2012 Q2 | 807.36 Million EUR | 2.55% |
| 2012 Q1 | 787.32 Million EUR | 8.21% |
| 2011 Q3 | 717.34 Million EUR | -6.6% |
| 2011 Q4 | 727.57 Million EUR | 1.43% |
| 2011 FY | 727.57 Million EUR | 5.43% |
| 2011 Q1 | 746.36 Million EUR | 8.15% |
| 2011 Q2 | 768.01 Million EUR | 2.9% |
| 2010 Q2 | 743.28 Million EUR | 4.5% |
| 2010 Q4 | 690.1 Million EUR | -0.69% |
| 2010 Q1 | 711.29 Million EUR | 10.83% |
| 2010 Q3 | 694.91 Million EUR | -6.51% |
| 2010 FY | 690.1 Million EUR | 7.53% |
| 2009 FY | 641.79 Million EUR | -1.98% |
| 2009 Q4 | 641.79 Million EUR | 0.0% |
| 2008 FY | 654.72 Million EUR | 12.58% |
| 2007 FY | 581.58 Million EUR | 9.06% |
| 2006 FY | 533.28 Million EUR | 6.33% |
| 2005 FY | 501.53 Million EUR | 12.29% |
| 2004 FY | 446.66 Million EUR | -16.89% |
| 2003 FY | 537.41 Million EUR | 41.54% |
| 2002 FY | 379.69 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | -107978.409% |
| Ansell Limited | 3.23 Billion USD | 38.621% |
| Ansell Limited | 3.24 Billion USD | 38.736% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | -306.256% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -661283.93% |
| Psykey, Inc. | 1.72 Million USD | -114904.747% |
| ConvaTec Group Plc | 3.7 Billion USD | 46.432% |
| ConvaTec Group Plc | 3.71 Billion USD | 46.508% |
| Encision Inc. | 3.81 Million USD | -52030.518% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -304640.589% |
| LifePoint, Inc. | 8.8 Million USD | -22450.885% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | -12350.15% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -221860.447% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | -36091.117% |
| Reflect Scientific, Inc. | 2.66 Million USD | -74333.054% |
| SmileDirectClub, Inc. | 597.06 Million USD | -232.72% |
| Sector 10, Inc. | 1000.00 USD | -198654500.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 58.145% |
| SheerVision, Inc. | 837.56 Thousand USD | -237081.114% |
| United Health Products, Inc. | 284.64 Thousand USD | -697807.906% |
| Vasamed, Inc. | 1.6 Million USD | -124040.271% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -890037.248% |
| Yubo International Biotech Limited | 2.34 Million USD | -84486.028% |